Literature DB >> 27564129

TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.

Hiroshi Okuda1, Satoshi Takahashi2, Akifumi Takaori-Kondo2, Akihiko Yokoyama1,2.   

Abstract

Gene rearrangement of the mixed lineage leukemia (MLL) gene causes leukemia by inducing the constitutive expression of a gene subset normally expressed only in the immature haematopoietic progenitor cells. MLL gene rearrangements often generate fusion products of MLL and a component of the AF4 family/ENL family/P-TEFb (AEP) complex. MLL-AEP fusion proteins have the potential of constitutively recruiting the P-TEFb elongation complex. Thus, it is hypothesized that relieving the promoter proximal pausing of RNA polymerase II is the rate-limiting step of MLL fusion-dependent transcription. AEP also has the potential to recruit the mediator complex via MED26. We recently showed that AEP activates transcription initiation by facilitating TBP loading to the TATA element through the SL1 complex. In the present study, we show that the key activity responsible for the oncogenic property of MLL-AEP fusion proteins is the TBP loading activity, and not the mediator recruitment or transcriptional elongation activities. Thus, we propose that TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.

Entities:  

Keywords:  AF4; MLL; SL1; TBP; leukemia; mediator; transcription

Mesh:

Substances:

Year:  2016        PMID: 27564129      PMCID: PMC5053588          DOI: 10.1080/15384101.2016.1222337

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  86 in total

1.  HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.

Authors:  Nanhai He; Min Liu; Joanne Hsu; Yuhua Xue; Seemay Chou; Alma Burlingame; Nevan J Krogan; Tom Alber; Qiang Zhou
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

2.  Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Authors:  Akihiko Yokoyama; Michael L Cleary
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

3.  AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79 methylation.

Authors:  Yuanyuan Li; Hong Wen; Yuanxin Xi; Kaori Tanaka; Haibo Wang; Danni Peng; Yongfeng Ren; Qihuang Jin; Sharon Y R Dent; Wei Li; Haitao Li; Xiaobing Shi
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

Review 4.  The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation.

Authors:  Sohail Malik; Robert G Roeder
Journal:  Nat Rev Genet       Date:  2010-10-13       Impact factor: 53.242

5.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

6.  The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

Authors:  Akihiko Yokoyama; Tim C P Somervaille; Kevin S Smith; Orit Rozenblatt-Rosen; Matthew Meyerson; Michael L Cleary
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

7.  Identification and distinct regulation of yeast TATA box-containing genes.

Authors:  Andrew D Basehoar; Sara J Zanton; B Franklin Pugh
Journal:  Cell       Date:  2004-03-05       Impact factor: 41.582

8.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.

Authors:  D C Tkachuk; S Kohler; M L Cleary
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  A TBP-containing multiprotein complex (TIF-IB) mediates transcription specificity of murine RNA polymerase I.

Authors:  D Eberhard; L Tora; J M Egly; I Grummt
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

10.  Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties.

Authors:  Akihiko Yokoyama; Issay Kitabayashi; Paul M Ayton; Michael L Cleary; Misao Ohki
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

View more
  10 in total

1.  Another piece of the puzzle added to understand t(4;11) leukemia better.

Authors:  Rolf Marschalek
Journal:  Haematologica       Date:  2019-06       Impact factor: 9.941

2.  Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.

Authors:  Hiroshi Okuda; Boban Stanojevic; Akinori Kanai; Takeshi Kawamura; Satoshi Takahashi; Hirotaka Matsui; Akifumi Takaori-Kondo; Akihiko Yokoyama
Journal:  J Clin Invest       Date:  2017-04-10       Impact factor: 14.808

3.  Myeloid Progenitor Transformation Assay.

Authors:  Hiroshi Okuda; Akihiko Yokoyama
Journal:  Bio Protoc       Date:  2017-12-05

4.  In vivo Leukemogenesis Model Using Retrovirus Transduction.

Authors:  Hiroshi Okuda; Akihiko Yokoyama
Journal:  Bio Protoc       Date:  2017-12-05

5.  The 3' Pol II pausing at replication-dependent histone genes is regulated by Mediator through Cajal bodies' association with histone locus bodies.

Authors:  Hidefumi Suzuki; Ryota Abe; Miho Shimada; Tomonori Hirose; Hiroko Hirose; Keisuke Noguchi; Yoko Ike; Nanami Yasui; Kazuki Furugori; Yuki Yamaguchi; Atsushi Toyoda; Yutaka Suzuki; Tatsuro Yamamoto; Noriko Saitoh; Shigeo Sato; Chieri Tomomori-Sato; Ronald C Conaway; Joan W Conaway; Hidehisa Takahashi
Journal:  Nat Commun       Date:  2022-05-25       Impact factor: 17.694

6.  Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation.

Authors:  Calla M Olson; Baishan Jiang; Michael A Erb; Yanke Liang; Zainab M Doctor; Zinan Zhang; Tinghu Zhang; Nicholas Kwiatkowski; Myriam Boukhali; Jennifer L Green; Wilhelm Haas; Tyzoon Nomanbhoy; Eric S Fischer; Richard A Young; James E Bradner; Georg E Winter; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2017-12-18       Impact factor: 16.174

Review 7.  Molecular processes involved in B cell acute lymphoblastic leukaemia.

Authors:  Camille Malouf; Katrin Ottersbach
Journal:  Cell Mol Life Sci       Date:  2017-08-17       Impact factor: 9.261

Review 8.  RNA Polymerase II-Dependent Transcription Initiated by Selectivity Factor 1: A Central Mechanism Used by MLL Fusion Proteins in Leukemic Transformation.

Authors:  Akihiko Yokoyama
Journal:  Front Genet       Date:  2019-01-14       Impact factor: 4.599

9.  Modeling by disruption and a selected-for partner for the nude locus.

Authors:  Jian Li; Yun-Kyoung Lee; Wenyu Fu; Anne M Whalen; Mario C Estable; Laurel A Raftery; Kristin White; Lorin Weiner; Janice L Brissette
Journal:  EMBO Rep       Date:  2020-12-28       Impact factor: 8.807

10.  Molecular pathogenesis of disease progression in MLL-rearranged AML.

Authors:  Shinichi Kotani; Akinori Yoda; Ayana Kon; Keisuke Kataoka; Yotaro Ochi; Yusuke Shiozawa; Cassandra Hirsch; June Takeda; Hiroo Ueno; Tetsuichi Yoshizato; Kenichi Yoshida; Masahiro M Nakagawa; Yasuhito Nannya; Nobuyuki Kakiuchi; Takuji Yamauchi; Kosuke Aoki; Yuichi Shiraishi; Satoru Miyano; Takahiro Maeda; Jaroslaw P Maciejewski; Akifumi Takaori-Kondo; Seishi Ogawa; Hideki Makishima
Journal:  Leukemia       Date:  2018-09-12       Impact factor: 11.528

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.